IDT is excited to attend the American Society of Human Genomics annual meeting in Los Angeles.
In March 2021, IDT acquired Swift Biosciences, a move that enhanced our ability to provide a more comprehensive NGS research portfolio. Now, you can uncover a flexible range of NGS solutions designed to help you sequence samples and generate research data you never thought you could.
In addition to our growing NGS portfolio, IDT continues to support researchers with complementary PCR solutions to complete your workflow.
2021 was a big year for the future of IDT’s xGen™ NGS portfolio. In addition to the Swift acquisition, we have new leadership in place and an expanded NGS team. Together, IDT is uniquely positioned to offer:
Our associates will be easy to spot at ASHG—you’ll find us wearing blue shirts!
Want to learn firsthand about the exciting products xGen NGS has to offer? Sign up for a one-on-one with an IDT expert while you’re at ASHG:
Throughout the ASHG event, you can also:
From bench to breakthrough. We’ll help.
To learn more, stop by Booth 1149 and attend the CoLab Session with Geneseeq Technologies
Date: October 26, 2022 | 3:00-3:30 p.m.
Presented by: Hai Meng Tang, Geneseeq Technologies Bioinformatician
Title: ctDNA for minimal residual disease research by hybridization capture in resected cancer samples